Atlas Trials

Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment

Clinical trial NCT07405476 · RECRUITING

Trial details

NCT number
NCT07405476
Sponsor
Emory University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Colon CarcinomaColorectal CarcinomaRectal CarcinomaStage I Colon Cancer AJCC v8Stage I Colorectal Cancer AJCC v8Stage I Rectal Cancer AJCC v8Stage II Colon Cancer AJCC v8Stage II Colorectal Cancer AJCC v8Stage II Rectal Cancer AJCC v8Stage III Colon Cancer AJCC v8Stage III Colorectal Cancer AJCC v8Stage III Rectal Cancer AJCC v8
Start date
2026-04-07
Primary completion
2028-12-18
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.